Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Moodys
Dow
Merck
AstraZeneca

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Radius Health Inc Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for RADIUS HEALTH INC, and when can generic versions of RADIUS HEALTH INC drugs launch?

RADIUS HEALTH INC has one approved drug.

There are four US patents protecting RADIUS HEALTH INC drugs.

There are thirty-two patent family members on RADIUS HEALTH INC drugs in twenty-five countries.

Summary for Radius Health Inc
International Patents:32
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Radius Health Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Radius Health Inc TYMLOS abaloparatide SOLUTION;SUBCUTANEOUS 208743-001 Apr 28, 2017 RX Yes Yes ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Radius Health Inc TYMLOS abaloparatide SOLUTION;SUBCUTANEOUS 208743-001 Apr 28, 2017 RX Yes Yes 10,996,208 ⤷  Sign up for a Free Trial Y ⤷  Sign up for a Free Trial
Radius Health Inc TYMLOS abaloparatide SOLUTION;SUBCUTANEOUS 208743-001 Apr 28, 2017 RX Yes Yes ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Radius Health Inc TYMLOS abaloparatide SOLUTION;SUBCUTANEOUS 208743-001 Apr 28, 2017 RX Yes Yes 8,748,382 ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Radius Health Inc TYMLOS abaloparatide SOLUTION;SUBCUTANEOUS 208743-001 Apr 28, 2017 RX Yes Yes 7,803,770 ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Radius Health Inc TYMLOS abaloparatide SOLUTION;SUBCUTANEOUS 208743-001 Apr 28, 2017 RX Yes Yes 8,148,333 ⤷  Sign up for a Free Trial Y ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for Radius Health Inc Drugs

Country Patent Number Estimated Expiration
Spain 2637283 ⤷  Sign up for a Free Trial
South Korea 20150020289 ⤷  Sign up for a Free Trial
Norway 20091545 ⤷  Sign up for a Free Trial
Slovenia 2957278 ⤷  Sign up for a Free Trial
Norway 344885 ⤷  Sign up for a Free Trial
Portugal 2957278 ⤷  Sign up for a Free Trial
Serbia 56164 ⤷  Sign up for a Free Trial
>Country >Patent Number >Estimated Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
AstraZeneca
Dow
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.